De-implementation of low value castration for men with prostate cancer: protocol for a theory-based, mixed methods approach to minimizing low value androgen deprivation therapy (DeADT)

De-implementation of low value castration for men with prostate cancer: protocol for a theory-based, mixed methods approach to minimizing low value androgen deprivation therapy (DeADT)

Abstract Background Men with prostate cancer are often castrated with long-acting injectable drugs termed androgen deprivation therapy (ADT). Although many benefit, ADT is also used in patients with little or nothing to gain. The best ways to stop this practice are unknown, and range from blunt phar...

Full description

Bibliographic Details
Main Authors: Ted A. Skolarus, Sarah T. Hawley, Daniela A. Wittmann, Jane Forman, Tabitha Metreger, Jordan B. Sparks, Kevin Zhu, Megan E. V. Caram, Brent K. Hollenbeck, Danil V. Makarov, John T. Leppert, Jeremy B. Shelton, Vahakn Shahinian, Sriram Srinivasaraghavan, Anne E. Sales
Format: Article
Language:English
Published: BMC 2018-11-01
Series:Implementation Science
Subjects:
Castration
De-implementation
Choosing wisely
Low value care
Implementation science
Intervention
Online Access:http://link.springer.com/article/10.1186/s13012-018-0833-7

Internet

http://link.springer.com/article/10.1186/s13012-018-0833-7

Similar Items